News Release: Evolva makes Veri-te resveratrol available for our companion animals.

June 3rd, 2021
|

03 June 2021 — Reinach, Switzerland

Evolva is bringing innovation to the pets market with the launch of Veri-teTM PETS resveratrol. This new application of Veri-teTM resveratrol is intended for use in companion animal dietary supplements to support age-related challenges and meet the growing pet parents demand for clean label, science-backed AND sustainably sourced ingredients.

Now one of the biggest players of the resveratrol market, Evolva disrupted the market in 2017, with the launch of Veri-teTM resveratrol, a new generation resveratrol made by an innovative fermentation process, making it available at the highest quality levels, at any time in any quantity.

Resveratrol is one of the most investigated compounds with more than 12,000 scientific publications and over 200 clinical trials. Used globally in various applications, resveratrol has raised attention not only for being a very effective antioxidant but also for exhibiting a number of complementary functions on cellular and systemic levels, leading to a plethora of beneficial health effects, making it the ingredient of choice to support healthy living at every life stage.

“Studies1 have shown that resveratrol is not only supporting pet parents healthy living. It is also showing many positive benefits for our family companion animals (dogs, cats, horses), particularly in the areas of joint and bone health, cardiovascular health, metabolic health, and cognitive health” explained Robb Thomas, B.Sc. Animal Science, in charge of Evolva’s business operations for animal health ingredients.

“Today pet parents have the same if not higher quality standards for their companion animal as for themselves” said Geraldine Blanc, Evolva’s Marketing Head. “They are also looking for supplements that are sourced responsibly and sustainably. Mainstream pet parents are starting to pay more attention to the environmental footprint of products and consequently ingredients with sustainable supply chains will be in more demand” Blanc added.

Available in the US market for use in pets dietary supplements, Veri-teTM PETS resveratrol is proposed at the highest quality level and can be formulated into multiple applications, including pellets, powder, and soft chews. Like Veri-teTM resveratrol, Veri-teTM PETS resveratrol is free from contaminants.

With this launch Evolva is not only confirming its leadership on the resveratrol market but also its ambition in the animal space after the EPA registration of its nootkatone active ingredient application (NootkaShield™) for pest control in the US last year.

“Veri-teTM PETS resveratrol brings resveratrol to the top of mind when formulators of the animal dietary supplements sector are seeking product differentiation with one ingredient, which impacts many areas of animal nutrition, while meeting their needs for quality, reliability and secured supply” concluded Thomas.


About Evolva
Evolva is a Swiss biotech company focused on the research, development and commercialization of products based on nature. We have leading businesses in Flavors and Fragrances, Health Ingredients and Health Protection. Evolva’s employees, half of which are women, are dedicated to make the best products that can contribute to health, wellbeing and sensory enjoyment. Find out more at www.evolva.com.

About Veri-teTM resveratrol
Veri-teTM resveratrol offers customers a guarantee of quality together with strong scientific backing and versatility in application, which can both inspire and enable customers to develop innovative and award-winning products.

For more information about Veri-teTM PETS resveratrol, visit our website:
https://veriteresveratrol.com/animal-health/

Clinical studies available at https://veriteresveratrol.com/benefits/

Media Contact
Géraldine BLANC
Marketing, Evolva
geraldineb@evolva.com

Disclaimer
This information is based on Evolva’s current knowledge and only contains scientific and technical information for business-to-business use. The documentation has not been reviewed by health authorities. The information contained in this document is presented as-is. Nothing herein relieves you from carrying out your own suitability determinations and tests including as to the stability testing of the finished product. Use of this information shall be at your own, sole discretion and risk. It does not relieve you of your obligations to comply with all applicable laws and regulations and to observe third party rights. Country- or region-specific requirements and restrictions should also be considered when labelling or advertising to end-customers. All trademarks included in this news release are trademarks of Evolva or its licensors in Switzerland and/or other countries.